Phase 2 study of VX-770 in cystic fibrosis subjectswith G551D
Ended Project Grant Awarded Last action
- Award ID
- R01FD003432
- Recipient
-
Vertex Pharmaceuticals Incorporated UEI Y4NLRU471XL7
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $350,000
Award facts
- Assistance listing
- 93.103 Food and Drug Administration Research
- Completion date
- Place of performance
- Massachusetts, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $350,000 | |
| Amendment | -$350,000 | |
| Original award | $350,000 |
Quick answers
Who received award R01FD003432?
R01FD003432 was awarded to Vertex Pharmaceuticals Incorporated by Food and Drug Administration (Department of Health and Human Services) on September 30, 2007.
How much is award R01FD003432 worth?
$350,000 has been obligated on R01FD003432.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award